Acceptability and preferences of six different routes of drug application for acute breathlessness: A comparison study between the United Kingdom and Germany

Journal of Palliative Medicine

Volumn 15, Issue 12, 2012, Pages 1374-1381

  Simon, Steffen T ^a,b,c   Niemand, Anna Maria ^a   Benalia, Hamid ^b   Voltz, Raymond ^a   Higginson, Irene J ^b   Bausewein, Claudia ^b,c,d  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Institute of Palliative Care   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPNEA; FEMALE; GERMANY; HEART FAILURE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; PATIENT COMPLIANCE; PATIENT PREFERENCE; PERSONAL EXPERIENCE; PRESCRIPTION; STRUCTURED INTERVIEW; UNITED KINGDOM;

ACUTE DISEASE; AGED; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION ROUTES; DYSPNEA; FEMALE; GERMANY; GREAT BRITAIN; HEART FAILURE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PALLIATIVE CARE; PATIENT PREFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITATIVE RESEARCH;

EID: 84870619751     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0249     Document Type: Article

References (20)

1. Booth S, Silvester S, Todd C: Breathlessness in cancer and chronic obstructive pulmonary disease: Using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003;1(4):337-344.
2. Solano JP, Gomes B, Higginson IJ: A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31(1):58-69.
3. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al.: An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea. Am J Respir Crit Care Med 2012;185(4):435-452.
4. Edmonds P, Karlsen S, Khan S, Addington-Hall J: A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001;15:287-295.
5. Tripodoro VA, De Vito EL: Management of dyspnea in advanced motor neuron diseases. Curr Opin Support Palliat Care 2008;2(3):173-179.
6. Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E: Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 2009;12(1):29-36.
7. Zeppetella G, O'Doherty CA, Collins S: Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage 2000;20(2):87-92.
8. Portenoy RK, Hagen NA: Breakthrough pain: Definition, prevalence and characteristics. Pain 1990;41(3):273-281.
9. Davies A, Zeppetella G, Andersen S, Damkier A, Vejlgaard T, Nauck F, et al.: Multi-centre European study of breakthrough cancer pain: Pain characteristics and patient per-ceptions of current and potential management strategies. Eur J Pain 2011;15(7):756-763.
10. Booth S, Moosavi SH, Higginson IJ: The etiology and management of intractable breathlessness in patients with advanced cancer: A systematic review of pharmacological therapy. Nat Clin Pract Oncol 2008;5(2):90-100.
11. Jennings AL, Davies AN, Higgins JP, Broadley K: Opioids for the palliation of breathlessness in terminal illness. Co-chrane Database Syst Rev 2001(4):CD002066.
12. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C: Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327(7414):523-528.
13. Coyne PJ, Viswanathan R, Smith TJ: Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J Pain Symptom Manage 2002;23(2):157-160.
14. Sitte T, Bausewein C: Intranasal fentanyl for episodic breathlessness. J Pain Symptom Manage 2008;36(6):e3-6.
15. Jensen D, Alsuhail A, Viola R, Dudgeon DJ, Webb KA, O'Donnell DE: Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage 2012;43(4):706-719.
16. Davis MP: Fentanyl for breakthrough pain: A systematic review. Expert Rev Neurother 2011;11(8):1197-1216.
17. Walker G, Wilcock A, Manderson C, Weller R, Crosby V: The acceptability of different routes of administration of analgesia for breakthrough pain. Palliat Med 2003;17(2):219-221.
18. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.
19. Heart Failure Society of America. New York Heart Association classification. 2002. www.abouthf.org/questions-stages.htm. (Last accessed February 6, 2012.)
20. Portenoy RK, Taylor D, Messina J, Tremmel L: A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 2006;22(9):805-811.